LXRX
Lexicon Pharmaceuticals, Inc.
Phase 3
AI-extracted
sotagliflozin
hypertrophic cardiomyopathy (HCM)
T-minus 222 days
~ Mar 31, 2027
SEC 8-K
verified 2mo ago
Countdown card →